By Todd Shriber via Iris.xyz It pays to be discerning in financial markets. The action in biotechnology stocks this year is a reminder of the benefits of that advice. For example, the large-cap Nasdaq Biotechnology Index is up just 0.53% (as of May 24th). The top four components in the Nasdaq Biotechnology Index are all large-cap [...] Read more on ETFtrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
This article was provided by our partner Tom Lydon of etftrends.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.